Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?
- PMID: 15905703
- DOI: 10.1097/01.mib.0000161918.04760.f3
Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?
Abstract
Background: Butyrate produced by colonic bacterial fermentation is the main fuel for colonocytes, glucose being an alternative fuel. During inflammatory bowel disease, butyrate oxidation by colonocytes is impaired, and increased production of proinflammatory cytokines is detected in the colonic mucosa. We hypothesized that proinflammatory cytokines might reduce butyrate oxidation, and we assessed the in vitro effects of 3 proinflammatory cytokines on butyrate and glucose oxidation in colonic mucosa.
Methods: Colonic biopsies were obtained from normal mucosa in 42 patients who underwent a colonoscopy. Biopsies were incubated in RPMI 1640 with [1-14C]-butyrate or [U-14C]-glucose with or without 1 of the 3 following proinflammatory cytokines: tumor necrosis factor alpha (TNFalpha), interleukin (IL)-1beta, and IL-6. For each cytokine, 4 different concentrations were tested in 8 subjects. Concentrations overlapped those commonly found in inflamed mucosa and had no cytotoxicity as assessed in preliminary experiments using both the trypan blue exclusion test and lactate dehydrogenase release. Production of 14CO2 (picomoles per microgram dry weight per hour) was measured after a 2-hour incubation and expressed as a percentage of the control [14C]-substrate oxidation without cytokines.
Results: Whereas glucose oxidation was not affected, butyrate oxidation was reduced significantly (P < 0.05) by TNFalpha at concentrations of 100 (-26 +/- 6%), 1000 (-32 +/- 7%), and 5000 pg/mL (-34 +/- 5%). IL-1beta (0, 500, 5000, and 25,000 pg/mL) and IL-6 (0, 100, 1000, and 5000 pg/mL) did not affect either substrate oxidation.
Conclusions: TNFalpha at concentrations found in inflamed mucosa reduces butyrate oxidation in vitro in mucosa from healthy controls. This result is not caused by a cytotoxic effect of TNFalpha and is not balanced by an increased oxidation of glucose. Reduced butyrate oxidation results in a decreased energy supply to colonocytes and may explain, in part, mucosal damage occurring during attacks of inflammatory bowel disease.
Similar articles
-
Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.Autoimmunity. 2000 Dec;32(4):255-63. doi: 10.3109/08916930008994099. Autoimmunity. 2000. PMID: 11191284
-
Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.Gut. 1994 Jan;35(1):73-6. doi: 10.1136/gut.35.1.73. Gut. 1994. PMID: 8307454 Free PMC article.
-
Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.Inflamm Bowel Dis. 2010 Apr;16(4):684-95. doi: 10.1002/ibd.21108. Inflamm Bowel Dis. 2010. PMID: 19774643 Review.
-
Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.Inflamm Bowel Dis. 2009 Mar;15(3):335-40. doi: 10.1002/ibd.20768. Inflamm Bowel Dis. 2009. PMID: 18942762
-
Review article: the role of butyrate on colonic function.Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19. doi: 10.1111/j.1365-2036.2007.03562.x. Epub 2007 Oct 25. Aliment Pharmacol Ther. 2008. PMID: 17973645 Review.
Cited by
-
Andrographolide derivative AL-1 ameliorates TNBS-induced colitis in mice: involvement of NF-кB and PPAR-γ signaling pathways.Sci Rep. 2016 Jul 20;6:29716. doi: 10.1038/srep29716. Sci Rep. 2016. PMID: 27435110 Free PMC article.
-
Effect of sialyllactose on growth performance and intestinal epithelium functions in weaned pigs challenged by enterotoxigenic Escherichia Coli.J Anim Sci Biotechnol. 2022 Mar 3;13(1):30. doi: 10.1186/s40104-022-00673-8. J Anim Sci Biotechnol. 2022. PMID: 35236420 Free PMC article.
-
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".Int J Inflam. 2012;2012:493717. doi: 10.1155/2012/493717. Epub 2012 Feb 29. Int J Inflam. 2012. PMID: 22518336 Free PMC article.
-
Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials.BMC Med. 2024 Mar 13;22(1):110. doi: 10.1186/s12916-024-03303-4. BMC Med. 2024. PMID: 38475833 Free PMC article.
-
Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice.Clin Exp Immunol. 2012 Feb;167(2):356-65. doi: 10.1111/j.1365-2249.2011.04498.x. Clin Exp Immunol. 2012. PMID: 22236013 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources